No Contraindications to Taking Journavx, Meloxicam, and Zyrtec Together
There are no contraindications to taking Journavx (suzetrigine), meloxicam, and Zyrtec (cetirizine) together. These medications work through different mechanisms and do not have clinically significant interactions with each other.
Key Drug Interaction Considerations
Journavx (Suzetrigine) Drug Interactions
The FDA label for Journavx specifies only two categories of contraindications and warnings 1:
- Contraindicated: Strong CYP3A inhibitors only
- Requires dose adjustment: Moderate CYP3A inhibitors
Neither meloxicam nor cetirizine are CYP3A inhibitors, so they do not interact with Journavx through this pathway.
Meloxicam Considerations
Meloxicam is an NSAID that primarily carries gastrointestinal and cardiovascular risks when used chronically 2. However, these are intrinsic drug effects, not drug-drug interactions with either Journavx or cetirizine.
Cetirizine (Zyrtec) Profile
Cetirizine is a second-generation antihistamine with minimal drug interactions 3. It may cause mild sedation at recommended doses (13.7% vs 6.3% placebo in patients ≥12 years) but does not interact pharmacokinetically with NSAIDs or Journavx 3.
Practical Clinical Guidance
You can safely prescribe all three medications together with these considerations:
Monitor for additive sedation: Both cetirizine and Journavx can cause drowsiness, though this is typically mild. Counsel patients about operating machinery or driving until they know how the combination affects them.
Standard NSAID precautions apply: Use meloxicam at the lowest effective dose for the shortest duration, particularly in patients with cardiovascular or gastrointestinal risk factors 2.
Journavx-specific requirements: Ensure the patient is not taking strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin, ritonavir) and take the loading dose on an empty stomach 1.
Common Pitfall to Avoid
Do not confuse the lack of interaction between these specific drugs with the general need to review all medications for CYP3A interactions when prescribing Journavx. The critical interaction to screen for is with CYP3A inhibitors—neither meloxicam nor cetirizine falls into this category.